NCT01864161View on ClinicalTrials.gov

Endovenous Versus Liposomal Iron in CKD

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Iron Deficiency AnemiaChronic Kidney Disease
Interventions
DRUG

gluconate iron

FERLIXIT fl 15mg/kg divided into weekly administrations of 125mg up to a maximum of 1000mg

DRUG

Liposomal iron

Sideral forte 30 mg/die

Trial Locations (1)

80131

Federico II University, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT01864161 - Endovenous Versus Liposomal Iron in CKD | Biotech Hunter | Biotech Hunter